For subscribers
Indian firm's sale of breast milk as proprietary medicine hits sour note
Sign up now: Get insights on Asia's fast-moving developments
DeeperDive is a beta AI feature. Refer to full articles for the facts.
An Indian company's commercialisation of human breast milk has drawn the ire of health activists and other professionals concerned that this "unethical" development could "open the door for many malpractices".
The Breastfeeding Promotion Network of India (BPNI) last Saturday urged the government to cancel Bangalore-based NeoLacta Lifesciences' licence that allows the firm to sell human breast milk as a "proprietary medicine".
